068 - Benefit/Risk Ratios, PRRC, and Mythical Medical with David Rutledge

Let's Combinate · 18 Jan 2023 · 47m

What this episode covers

David Rutledge, CEO of Global Strategic Solutions and author of 'Mythical Medical', discusses the critical importance of demonstrating product benefit in medical device development, arguing that the industry has historically focused too heavily on risk. He details the role of the Person Responsible for Regulatory Compliance (PRRC) under EU MDR, emphasizing the need for cross-functional teams to define and validate benefits through diverse data sources. Rutledge also shares insights from his book, using narrative characters to illustrate common regulatory pitfalls, audit preparation strategies, and the emotional weight of ensuring patient safety in combination products.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 40m

    How Jon Speer Met His Most Frequent Guest: Mike Drues

    Jon Speer, host of the Global Medical Device Podcast and founder of Greenlight Guru, revisits his 2014 origin story with Mike Drues, president of Vascular Sciences, to discuss their past debates on medical device design controls. They analyze the tension between following the literal letter of FDA regulations versus understanding their intent, arguing that many companies fail because they treat compliance as a checkbox exercise rather than a rigorous engineering process. The conversation highlights the danger of assuming users know their own needs, which stifles revolutionary product development in favor of evolutionary improvements, and emphasizes the critical importance of validating validation methods and addressing off-label use in risk management.

  • Global Medical Device Podcast · 50m

    The Best of Jon & Mike Through the Years

    Jon Speer, founder of Greenlight Guru, and Mike Drues of Vascular Sciences reflect on their 107-episode podcast partnership, discussing key regulatory strategies including the 510(k), De Novo, and Emergency Use Authorization (EUA). They emphasize the importance of understanding all market pathways, interpreting regulations rather than just following them blindly, and conducting realistic usability testing. The conversation highlights the critical mindset of asking whether one would use the device on a family member, underscoring the gravity of medical device development.

  • Global Medical Device Podcast · 22m

    Risk Management from a Regulatory & Product Development Point of View

    Host John Speer and guest Mike Drues, president of Vascular Sciences, discuss the complexities of risk management in medical device development, specifically focusing on the tension between regulatory documentation and product liability. They analyze ISO 14971 and TR 24971 as frameworks, highlighting the dilemma of addressing off-label use in risk assessments to avoid higher liability exposure. The conversation covers strategies for limiting discussion to on-label risks while still considering unintentional misuse, and concludes with advice on navigating FDA interactions regarding intended use.

  • Global Medical Device Podcast · 40m

    #365: Medical Device Reporting: The Do's and Don'ts

    Lisa Van Ryn, a medical device guru at Greenlight Guru, explains the FDA’s Medical Device Reporting (MDR) requirements, detailing how manufacturers must evaluate complaints to determine reportability under 21 CFR Part 803. She outlines a decision tree for identifying serious injuries and device malfunctions, emphasizing that the reporting clock starts when any company employee becomes aware of an event, not just quality staff. Van Ryn highlights the distinction between 5-day and 30-day reports based on the need for remedial action to prevent public health risks, and warns against the pitfalls of ignoring customer feedback for trend analysis.

  • Global Medical Device Podcast · 39m

    #362: Managing Risk in Clinical Investigations

    Helene Quie, a medical device regulatory expert, explains the dual nature of risk management in clinical investigations, distinguishing between residual product safety risks and procedural risks inherent in study protocols. She emphasizes the need for measurable, data-driven benefit-risk assessments to satisfy ethics committees and competent authorities, particularly under the EU MDR. Quie highlights the operational challenges of enrolling vulnerable patient populations, such as children or acute patients, and the regulatory confusion surrounding the integration of AI in medical devices.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.